What's New

Last Posted: Jun 13, 2024

• Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
  Lauren G Banaszak et al. JCO Precis Oncol 2024 8e2300518
• Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia
  
• Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia.
  Andrew Seto et al. Cancers (Basel) 2024 16(9)
• Advancing hospital-based health technology assessment: evaluating genomic panel contracting strategies for blood tumors through a multimethodology.
  Susana Afonso et al. Int J Technol Assess Health Care 2023 39(1) e76
• The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.
  Julie Bergeron et al. Curr Oncol 2023 30(12) 10410-10436
• Older Patients With AML Less Likely to Receive Genomic Testing, Study Finds
  P Steinzor, AJMC, August 29, 2023
• Management of Down Syndrome-Associated Leukemias: A Review.
  Anupam Verma et al. JAMA Oncol 2023
• Telomere Length and Clonal Hematopoiesis.
  George Vassiliou et al. N Engl J Med 2023 5 (26) 2481-2484
• Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience.
  Aleksandra Borkovskaia et al. Genes 2023 14(3)
• A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
  Qiujin Shen et al. Cancer research communications 2023 2(4) 258-276
• The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency.
  Marta Santiago et al. Cancers 2023 15(5)
• Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia.
  Yong Liu et al. Frontiers in genetics 2023 131087938
• Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
  Sargas Claudia et al. Cancers 2023 15(2)
• Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America.
  Gómez-De León Andrés et al. Hematology (Amsterdam, Netherlands) 2023 28(1) 2158015
• Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.
  Fitzhugh Courtney D et al. Hematology. American Society of Hematology. Education Program 2022 2022(1) 266-271
• Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.
  Ganzel Chezi et al. Leukemia research 2022 123106971
• Unified classification and risk-stratification in Acute Myeloid Leukemia.
  Tazi Yanis et al. Nature communications 2022 8 (1) 4622
• Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia.
  Matos Sónia et al. Cancers 2022 14(13)
• Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia.
  Xu Zi-Jun et al. Molecular therapy oncolytics 2022 2688-104
• How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia.
  Moore Jozal W et al. Current treatment options in oncology 2022
• Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality.
  Liu Jie et al. Hematology (Amsterdam, Netherlands) 2022 27(1) 565-574
• A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
  Wang Meifang et al. Frontiers in oncology 2022 12844978
• Comprehensive mutation profile in acute myeloid leukemia patients with RUNX1-RUNX1T1 or CBFB-MYH11 fusions.
  Qin Wei et al. Turkish journal of haematology : official journal of Turkish Society of Haematology 2022
• WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients.
  Koczkodaj Dorota et al. Journal of clinical medicine 2022 11(7)
• A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients.
  Yang Min et al. Frontiers in oncology 2022 11783114
• A Machine Learning Approach to the Classification of Acute Leukemias and Distinction From Nonneoplastic Cytopenias Using Flow Cytometry Data.
  Monaghan Sara A et al. American journal of clinical pathology 2021
• Incorporating genetic counseling into the evaluation of pediatric bone marrow failure.
  Schneider Kami Wolfe et al. Journal of genetic counseling 2021
• Adult Acute Myeloid Leukemia with the KMT2A-Mixed Lineage Leukemia T10 Fusion: An Analysis of 10 Cases Showed Common Features and Frequent Mutations in the RAS Signaling Pathway.
  Cai Xiaohui et al. Acta haematologica 2021 1-7
• Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia.
  Wang Youjin et al. Scientific reports 2021 11(1) 15004
• DNA methylation analysis improves the prognostication of acute myeloid leukemia.
  Samimi Hanie et al. EJHaem 2021 2(2) 211-218

More